Add BrightSurf on Google Email

Xia & He Publishing Inc.


Serum interleukin-8 for differentiating invasive pulmonary aspergillosis from bacterial pneumonia in patients with HBV-associated acute-on-chronic liver failure

A study found that serum interleukin-8 (IL-8) levels can differentiate invasive pulmonary aspergillosis from bacterial pneumonia in patients with HBV-associated acute-on-chronic liver failure. IL-6 levels were significantly higher in IPA patients compared to non-infection controls.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJan 28, 2026

TF-rs1049296 C>T variant modifies the association between hepatic iron stores and liver fibrosis in metabolic dysfunction-associated steatotic liver disease

A study found that the TF-rs1049296 C>T variant is associated with a higher risk of significant liver fibrosis in patients with MASLD, particularly in those with RES iron deposition. The variant was also linked to increased risk of SF in mixed hepatocellular/RES iron deposition patterns.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJan 28, 2026

Oxytocin attenuates metabolic dysfunction-associated steatotic liver disease via AMPK/SREBP1c/FAS-mediated suppression of hepatic lipogenesis

Researchers investigated the therapeutic potential and molecular mechanisms of oxytocin in metabolic dysfunction-associated steatotic liver disease (MASLD). Oxytocin attenuates lipid accumulation and accelerates lipid metabolism by regulating the AMPK/SREBP1c/FAS axis.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJan 26, 2026

Fecal microbiome and bile acid profiles differ in preterm infants with parenteral nutrition-associated cholestasis

This study found differences in fecal microbiome and bile acid content between preterm infants with parenteral nutrition-associated cholestasis (PNAC) and those without PNAC. PNAC development was associated with higher abundance of Proteobacteria, Fusobacteriota, and lower Bacteroidota in cholestatic infants.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJan 24, 2026

Current and emerging issues in familial hypobetalipoproteinemia-related steatotic liver diseases

FHBL is characterized by low plasma levels of total cholesterol, LDL-C, and APOB, and its pathogenesis involves lipid overload, ER stress, oxidative damage, and autophagic dysfunction. Current challenges include underdiagnosis, sparse epidemiological data, and unclear disease progression mechanisms.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJan 23, 2026

Quality and quantity? The clinical significance of myosteatosis in various liver diseases

Myosteatosis is a key predictor of poor clinical outcomes across a spectrum of liver diseases, with associations to severe disease phenotypes, hepatocellular carcinoma, and increased mortality. Nutritional intervention, exercise prescription, and potential management strategies are proposed to address this condition.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJan 22, 2026

Global prevalence, temporal trends, and associated mortality of bacterial infections in patients with liver cirrhosis

Bacterial infections are common and severe complications in patients with liver cirrhosis, with a global prevalence of 35.1% reported. The most common infection sites were the gastrointestinal tract, ascites fluid, and urinary tract, with gram-negative organisms more frequent than gram-positive organisms.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJan 22, 2026

Expert consensus on clinical applications of fecal microbiota transplantation for chronic liver disease (2025 edition)

Fecal microbiota transplantation (FMT) holds promise in treating chronic liver diseases by restoring gut-liver axis balance. The consensus recommends FMT for various etiologies, excluding drug-induced liver injury, with strict donor selection and management guidelines to ensure safety.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJan 22, 2026

Artificial Intelligence-driven Strategies and Modern Innovations to Surpass Biopharmaceutic Limitations in Traditional Drug Development

The integration of AI predictive tools and novel formulations, such as 3D printing and biodegradable nanocarriers, is transforming the approach to traditional drug development. These cutting-edge technologies are improving drug absorption and bioavailability by predicting and overcoming biopharmaceutic challenges.

SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateDec 8, 2025

Protective effects of Sclerocarya birrea in vivo

The study found that S. birrea extract reversed behavioral alterations caused by monosodium glutamate, reduced oxidative stress parameters, and counteracted malondialdehyde levels. These results support the potential of S. birrea as a neuroprotective agent for preventing and treating cognitive deficits.

SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateDec 8, 2025

Hematological and biochemical serum markers in breast cancer: Diagnostic, therapeutic, and prognostic significance

Serum markers such as NLR, PLR, ESR, LDH, ALP, creatine kinase-BB, SUA, CRP, and CA 15-3/27.29 have been linked to breast cancer diagnosis, prognosis, and therapeutic monitoring. These biomarkers offer affordable, non-invasive, and accessible diagnostic strategies for bridging the diagnostic gap in low-resource settings.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateNov 27, 2025

Global burden and mortality of amyotrophic lateral sclerosis and other motor neuron diseases in 204 countries and territories, 1990–2021

The study examines the global epidemiology of amyotrophic lateral sclerosis (ALS) and other motor neuron diseases (MNDs), revealing a rising global burden with significant variations across regions. Regional factors contribute to these diseases, emphasizing the need for optimized medical resources and further research.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateNov 26, 2025

Comparison of pre-procedure lignocaine spray vs. spray-as-you-go for topical airway anesthesia in flexible bronchoscopy

This study compared pre-procedure lignocaine spray (PPL) and spray-as-you-go (SAYG) airway anesthesia in fiberoptic bronchoscopy. The results showed no significant differences in patient-reported pain, discomfort, coughing, or procedure duration between the two groups. However, operator comfort was slightly higher with the PPL protocol.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateNov 25, 2025

Stereotactic radiosurgery for craniopharyngioma management

Craniopharyngiomas are managed effectively with stereotactic radiosurgery (SRS), which provides high-dose radiation to tumors while minimizing risks to surrounding tissues. Studies have shown comparable control rates to conventional radiotherapy, but SRS is associated with lower incidence of hypothalamic obesity and long-term sequelae.

SourceXia & He Publishing Inc.·JournalNeurosurgical Subspecialties·DateNov 19, 2025

State-of-the-art multimodal imaging and therapeutic strategies in radiation-induced brain injury

Recent advances in multimodal imaging, including MRI, diffusion imaging, perfusion imaging, MRS, and PET/CT, have improved early detection and differential diagnosis of radiation-induced brain injury (RIBI). Emerging therapeutic strategies target underlying pathological mechanisms, such as neuroinflammation, oxidative stress, and vascu...

SourceXia & He Publishing Inc.·JournalNeurosurgical Subspecialties·DateNov 18, 2025

Consensus on the management of liver injury associated with targeted drugs and immune checkpoint inhibitors for hepatocellular carcinoma (version 2024)

The Chinese Society of Hepatology outlines a structured framework for monitoring, diagnosing, preventing, and managing drug-induced liver injury in patients with hepatocellular carcinoma. Key risk factors include underlying liver disease, genetic predisposition, and drug-specific factors.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateNov 17, 2025

Hepatosplenic volumes and portal pressure gradient identify one-year further decompensation risk post-transjugular intrahepatic portosystemic shunt

A retrospective cohort study found that right hepatic lobe volume, spleen volume, and portal pressure gradient reduction predict further decompensation in cirrhotic patients post-TIPS. A nomogram model demonstrated high discriminative accuracy in identifying high-risk patients.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateNov 13, 2025

The mechanisms behind thrombocytopenia in patients with portal hypertension and chronic liver disease

Thrombocytopenia is a hallmark of portal hypertension and cirrhosis, with impaired production, increased destruction, and sequestration being key mechanisms. Diagnostic approaches include non-invasive methods like transient elastography and serological markers, while integrated management addresses both PH and thrombocytopenia.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateNov 12, 2025

Clinical characteristics and outcomes of portal vein thrombosis in patients with porto-sinusoidal vascular disease

A study of 169 patients with porto-sinusoidal vascular disease found that portal vein thrombosis was associated with higher rates of esophageal variceal bleeding, ascites, and antithrombin III deficiency. The study also reported a higher risk of mortality in patients with PVT compared to those without.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateNov 11, 2025

Mapping metabolic dysfunction-associated steatotic liver disease models of care across 17 Middle East and North Africa countries: Insights into guidelines, infrastructure, and referral systems

This study reveals limited national strategies, weak guideline implementation, and underutilized multidisciplinary collaboration in MASLD care across the MENA region. The insights gathered from regional experts highlight systemic challenges and actionable opportunities for improvement.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateNov 11, 2025

Gut microbiota: implications in pathogenesis and potential therapeutic target in primary biliary cholangitis

Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease characterized by immune-mediated destruction of small intrahepatic bile ducts. Recent studies have highlighted the significance of gut microbiota dysbiosis in PBC, with reduced diversity and imbalanced flora contributing to disease progression. The gut microbiome a...

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateNov 10, 2025

Autoimmune hepatitis associated with other autoimmune diseases

Autoimmune hepatitis is often associated with other autoimmune conditions, including thyroid disease, type 1 diabetes, inflammatory bowel disease, and rheumatologic disorders. The study highlights the need for precise diagnostic criteria and interdisciplinary management strategies to optimize outcomes in patients with multi-organ autoi...

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateNov 10, 2025

Arctigenin prevents metabolic dysfunction-associated steatohepatitis by inhibiting NLRP3/GSDMD-N axis in macrophages

Arctigenin, a monomer of Fructus Arctii, exhibits anti-inflammatory activity and prevents MASH progression through modulating the NLRP3/GSDMD-N axis in macrophages. ATG administration also reduces hepatic macrophage infiltration, serum enzyme levels, and lipid peroxidation while enhancing antioxidant enzyme activity.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateNov 6, 2025

Disrupted connectivity of the brainstem ascending reticular activating system nuclei-left parahippocampal gyrus could reveal mechanisms of delirium following basal ganglia intracerebral hemorrhage

Delirium in critically ill patients with basal ganglia intracerebral hemorrhage shows disrupted connectivity between the brainstem's ascending reticular activating system nuclei and the left parahippocampal gyrus. This disruption is linked to delirium occurrence and may serve as a biomarker for prediction.

SourceXia & He Publishing Inc.·JournalNeurosurgical Subspecialties·DateOct 31, 2025

Opportunities and challenges of multimodal electroencephalography and functional near infrared spectroscopy in neurological disorders

This study analyzed global publications of EEG-fNIRS synchronization techniques for their diagnostic and therapeutic value in clinical applications. The research identified hotspots, development trends, and future directions in neurology, emphasizing the importance of multimodal technology for disease diagnosis and treatment.

SourceXia & He Publishing Inc.·JournalNeurosurgical Subspecialties·DateOct 30, 2025

Deep Learning for Enhancing High-resolution Blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI)

Recent advances in deep learning techniques have overcome limitations in spatial and temporal resolution of BOLD-fMRI. DL models improve image quality through super-resolution reconstruction, automate segmentation, and enhance registration, enabling finer localization of neural activity and more precise brain activity quantification.

SourceXia & He Publishing Inc.·JournalNeurosurgical Subspecialties·DateOct 30, 2025